ReviewCurrent oncology (Toronto, Ont.)2015

Novel agents and associated toxicities of inhibitors of the pi3k/Akt/mtor pathway for the treatment of breast cancer.

S Chia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.